Gongwin Biopharm Holdings Statistics
Total Valuation
TPEX:6617 has a market cap or net worth of TWD 12.66 billion. The enterprise value is 10.39 billion.
Market Cap | 12.66B |
Enterprise Value | 10.39B |
Important Dates
The last earnings date was Thursday, March 13, 2025.
Earnings Date | Mar 13, 2025 |
Ex-Dividend Date | n/a |
Share Statistics
TPEX:6617 has 126.60 million shares outstanding. The number of shares has increased by 6.84% in one year.
Current Share Class | n/a |
Shares Outstanding | 126.60M |
Shares Change (YoY) | +6.84% |
Shares Change (QoQ) | +1.38% |
Owned by Insiders (%) | 24.20% |
Owned by Institutions (%) | 0.04% |
Float | 58.20M |
Valuation Ratios
PE Ratio | n/a |
Forward PE | n/a |
PS Ratio | n/a |
PB Ratio | 4.16 |
P/TBV Ratio | 4.08 |
P/FCF Ratio | n/a |
P/OCF Ratio | n/a |
PEG Ratio | n/a |
Enterprise Valuation
EV / Earnings | -125.88 |
EV / Sales | n/a |
EV / EBITDA | n/a |
EV / EBIT | n/a |
EV / FCF | -35.43 |
Financial Position
The company has a current ratio of 13.36, with a Debt / Equity ratio of 0.04.
Current Ratio | 13.36 |
Quick Ratio | 13.26 |
Debt / Equity | 0.04 |
Debt / EBITDA | n/a |
Debt / FCF | -0.43 |
Interest Coverage | -37.67 |
Financial Efficiency
Return on equity (ROE) is -4.17% and return on invested capital (ROIC) is -4.39%.
Return on Equity (ROE) | -4.17% |
Return on Assets (ROA) | -4.14% |
Return on Invested Capital (ROIC) | -4.39% |
Return on Capital Employed (ROCE) | -5.06% |
Revenue Per Employee | n/a |
Profits Per Employee | n/a |
Employee Count | n/a |
Asset Turnover | 0.01 |
Inventory Turnover | 3.01 |
Taxes
Income Tax | n/a |
Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -48.05% in the last 52 weeks. The beta is 0.56, so TPEX:6617's price volatility has been lower than the market average.
Beta (5Y) | 0.56 |
52-Week Price Change | -48.05% |
50-Day Moving Average | 109.00 |
200-Day Moving Average | 117.96 |
Relative Strength Index (RSI) | 43.59 |
Average Volume (20 Days) | 119,211 |
Short Selling Information
Short Interest | n/a |
Short Previous Month | n/a |
Short % of Shares Out | n/a |
Short % of Float | n/a |
Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, TPEX:6617 had revenue of TWD 32.04 million and -82.55 million in losses. Loss per share was -0.68.
Revenue | 32.04M |
Gross Profit | 8.68M |
Operating Income | -162.06M |
Pretax Income | -91.86M |
Net Income | -82.55M |
EBITDA | -150.47M |
EBIT | -162.06M |
Loss Per Share | -0.68 |
Balance Sheet
The company has 2.39 billion in cash and 126.75 million in debt, giving a net cash position of 2.26 billion or 17.88 per share.
Cash & Cash Equivalents | 2.39B |
Total Debt | 126.75M |
Net Cash | 2.26B |
Net Cash Per Share | 17.88 |
Equity (Book Value) | 3.10B |
Book Value Per Share | 24.05 |
Working Capital | 2.25B |
Cash Flow
In the last 12 months, operating cash flow was -87.41 million and capital expenditures -205.89 million, giving a free cash flow of -293.30 million.
Operating Cash Flow | -87.41M |
Capital Expenditures | -205.89M |
Free Cash Flow | -293.30M |
FCF Per Share | -2.32 |
Margins
Gross margin is 27.09%, with operating and profit margins of -505.80% and -257.64%.
Gross Margin | 27.09% |
Operating Margin | -505.80% |
Pretax Margin | -286.69% |
Profit Margin | -257.64% |
EBITDA Margin | n/a |
EBIT Margin | n/a |
FCF Margin | n/a |
Dividends & Yields
TPEX:6617 does not appear to pay any dividends at this time.
Dividend Per Share | n/a |
Dividend Yield | n/a |
Dividend Growth (YoY) | n/a |
Years of Dividend Growth | n/a |
Payout Ratio | n/a |
Buyback Yield | -6.84% |
Shareholder Yield | -6.84% |
Earnings Yield | -0.65% |
FCF Yield | -2.32% |
Stock Splits
This stock does not have any record of stock splits.
Last Split Date | n/a |
Split Type | n/a |
Split Ratio | n/a |
Scores
Altman Z-Score | n/a |
Piotroski F-Score | n/a |